IXICO plc (GB:IXI) has released an update.
IXICO plc announced the successful completion of its General Meeting, where shareholders approved the issuance of 42.6 million new ordinary shares, boosting the company’s total voting rights to over 92.6 million. This strategic move aims to enhance IXICO’s capabilities in delivering advanced analytics for neurological research and clinical trials.
For further insights into GB:IXI stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
